Ben Ke

607 total citations
45 papers, 425 citations indexed

About

Ben Ke is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ben Ke has authored 45 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Nephrology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ben Ke's work include Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (7 papers) and Renal and related cancers (7 papers). Ben Ke is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (7 papers) and Renal and related cancers (7 papers). Ben Ke collaborates with scholars based in China. Ben Ke's co-authors include Xiangdong Fang, Liping Yang, Wen Shen, Qinghua Wu, Yanxia Chen, Yanxia Chen, Weiping Tu, Jing Hu, Jianjun Xu and Yunfei Liao and has published in prestigious journals such as The Science of The Total Environment, Scientific Reports and Medicine.

In The Last Decade

Ben Ke

37 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ben Ke China	12	178	105	80	57	47	45	425
Keita Mori Japan	13	223 1.3×	141 1.3×	134 1.7×	58 1.0×	70 1.5×	32	594
Qiuju Wei China	12	130 0.7×	159 1.5×	76 0.9×	37 0.6×	58 1.2×	33	384
Feng-Ying Lei China	15	201 1.1×	169 1.6×	64 0.8×	33 0.6×	41 0.9×	33	508
Edgar Maquigussa Brazil	12	218 1.2×	111 1.1×	57 0.7×	37 0.6×	93 2.0×	28	456
Jerry Ricks United States	11	118 0.7×	88 0.8×	74 0.9×	48 0.8×	69 1.5×	14	550
Taisuke Baba Japan	7	133 0.7×	58 0.6×	83 1.0×	43 0.8×	53 1.1×	25	353
Yoshiaki Hirayama Japan	11	159 0.9×	240 2.3×	59 0.7×	27 0.5×	39 0.8×	23	455
Ming Xia China	12	92 0.5×	116 1.1×	106 1.3×	46 0.8×	52 1.1×	44	440
Wei-Fang Huang China	15	172 1.0×	152 1.4×	65 0.8×	27 0.5×	38 0.8×	24	470

Countries citing papers authored by Ben Ke

Since Specialization

Citations

This map shows the geographic impact of Ben Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Ke more than expected).

Fields of papers citing papers by Ben Ke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Ke. The network helps show where Ben Ke may publish in the future.

Co-authorship network of co-authors of Ben Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Ke. A scholar is included among the top collaborators of Ben Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Ke. Ben Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xueting, Yan Peng, Lu Zhang, et al.. (2025). The efficacy and safety of half-dose glucocorticoids combined with rituximab versus high-dose glucocorticoids for initial treatment of minimal change disease: a single-center experience. Frontiers in Pharmacology. 15. 1403562–1403562. 1 indexed citations

Chen, Yanxia, et al.. (2025). Angiotensin-(1–7) Mitigates Progression from Acute Kidney Injury to Chronic Kidney Disease Via Renin-Angiotensin System Modulation in a Murine Model. Inflammation. 48(6). 4492–4503.

Zhou, Zijian, et al.. (2025). How to Choose Treatment Regimens for Idiopathic Membranous Nephropathy Patients with PLA2R-Negative: A Single-Center Retrospective Cohort Study. ImmunoTargets and Therapy. Volume 14. 515–522.

Chen, Yanxia, et al.. (2024). Wnt/β-catenin Pathway Aggravates Renal Fibrosis by Activating PUM2 Transcription to Repress YME1L-mediated Mitochondrial Homeostasis. Biochemical Genetics. 63(2). 1343–1360. 1 indexed citations

Chen, Yanxia, et al.. (2024). Relationship of serum calcium concentration with chronic kidney disease and mortality in type 2 diabetes mellitus patients: evidence from the NHANES 1999–2018. International Urology and Nephrology. 57(3). 1009–1018.

Ke, Ben, et al.. (2024). Identification of molecular mediators of renal sarcopenia risk: a mendelian randomization analysis. The journal of nutrition health & aging. 28(1). 100019–100019. 1 indexed citations

Ke, Ben, et al.. (2024). Bioinformatics reveals the pathophysiological relationship between diabetic nephropathy and periodontitis in the context of aging. Heliyon. 10(2). e24872–e24872. 5 indexed citations

Ke, Ben, et al.. (2024). Mendelian randomization analysis reveals higher whole body water mass may increase risk of bacterial infections. BMC Medical Genomics. 17(1). 183–183.

Wu, Tao, et al.. (2024). Analysis of regulatory patterns of NLRP3 corpuscles and related genes and the role of macrophage polarization in atherosclerosis based on online database. Molecular Genetics and Genomics. 300(1). 7–7. 1 indexed citations

10.

Ke, Ben, et al.. (2023). Association of nocturia of self-report with estimated glomerular filtration rate: a cross-sectional study from the NHANES 2005–2018. Scientific Reports. 13(1). 13924–13924. 4 indexed citations

11.

Fang, Xiangdong, Yanxia Chen, Shuying Zhu, et al.. (2023). LncRNA SNHG1 knockdown inhibits hyperglycemia induced ferroptosis viamiR‐16‐5p/ACSL4 axis to alleviate diabetic nephropathy. Journal of Diabetes Investigation. 14(9). 1056–1069. 24 indexed citations

12.

Song, Lei, et al.. (2023). Annexin A1 may contribute to the morphological changes in podocytes by mediating endocytic vesicle fusion and transport via promotion of SNARE assembly in idiopathic membranous nephropathy. Nephrology. 29(2). 76–85. 1 indexed citations

13.

Liao, Yunfei, Ben Ke, Xiaoyan Long, Jianjun Xu, & Yongbing Wu. (2023). Abnormalities in the SIRT1-SIRT3 axis promote myocardial ischemia-reperfusion injury through ferroptosis caused by silencing the PINK1/Parkin signaling pathway. BMC Cardiovascular Disorders. 23(1). 582–582. 23 indexed citations

14.

Ke, Ben, et al.. (2022). circPlekha7 suppresses renal fibrosis via targeting miR-493-3p/KLF4. Epigenomics. 14(4). 199–217. 7 indexed citations

15.

Chen, Yanxia, Lei Zeng, Xianfeng Wu, et al.. (2022). Clinical study on the use of advanced magnetic resonance imaging in lupus nephritis. BMC Medical Imaging. 22(1). 210–210. 3 indexed citations

16.

Cao, Huiling, et al.. (2022). Alterations of amplitude of low-frequency fluctuations and fractional amplitude of low-frequency fluctuations in end-stage renal disease on maintenance dialysis: An activation likelihood estimation meta-analysis. Frontiers in Human Neuroscience. 16. 1040553–1040553. 2 indexed citations

17.

Ke, Ben, et al.. (2022). VEGFA promotes the occurrence of PLA2R-associated idiopathic membranous nephropathy by angiogenesis via the PI3K/AKT signalling pathway. BMC Nephrology. 23(1). 313–313. 2 indexed citations

18.

Fang, Xiangdong, Jing Hu, Yanxia Chen, Wen Shen, & Ben Ke. (2020). Dickkopf-3: Current Knowledge in Kidney Diseases. Frontiers in Physiology. 11. 533344–533344. 37 indexed citations

19.

Ke, Ben, et al.. (2017). Matrix Metalloproteinases-7 and Kidney Fibrosis. Frontiers in Physiology. 8. 21–21. 68 indexed citations

20.

Ke, Ben, et al.. (2015). The Role of Krüppel-like Factor 4 in Renal Fibrosis. Frontiers in Physiology. 6. 327–327. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact